Published in AIDS Weekly, December 20th, 2004
The drugs, lamivudine tablets and a combination of lamivudine and zidovudine, both made by Cipla Ltd., are the first of 18 Indian generic drugs that have been removed from the list this year to regain World Health Organization (WHO) approval.
"Two extremely important drugs are once again on the list and recommended for use by all our U.N. partners in developing countries," said Jim Kim, WHO's AIDS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.